Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review

Journal of Hepatology - Tập 56 Số 1 - Trang 255-266 - 2012
Christian Thoma1,2,3, Christopher P. Day1,3, Michael I. Trenell1,2,3
1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
2MRC Centre for Brain Ageing & Vitality, Newcastle University, Newcastle upon Tyne, UK
3NIHR Biomedical Research Centre for Ageing & Age-related Disease, Newcastle University, Newcastle upon Tyne, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Day, 2006, Non-alcoholic fatty liver disease: current concepts and management strategies, Clin Med, 6, 19, 10.7861/clinmedicine.6-1-19

Barshop, 2008, Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 28, 13, 10.1111/j.1365-2036.2008.03703.x

Fabbrini, 2010, Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications, Hepatology, 51, 679, 10.1002/hep.23280

Kotronen, 2008, Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects, Diabetes Care, 31, 165, 10.2337/dc07-1463

Kotronen, 2008, Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes, Gastroenterology, 135, 122, 10.1053/j.gastro.2008.03.021

Angelico, 2005, Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease, J Clin Endocrinol Metab, 90, 1578, 10.1210/jc.2004-1024

Fraser, 2009, Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis, Diabetes Care, 32, 741, 10.2337/dc08-1870

Targher, 2010, Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease, N Engl J Med, 363, 1341, 10.1056/NEJMra0912063

Loria, 2010, Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee, Dig Liver Dis, 42, 272, 10.1016/j.dld.2010.01.021

Merriman, 2006, Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease, Hepatology, 44, 874, 10.1002/hep.21346

Larson, 2007, Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass, Clin Gastroenterol Hepatol, 5, 1329, 10.1016/j.cgh.2007.06.005

Schwenzer, 2009, Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance, J Hepatol, 51, 433, 10.1016/j.jhep.2009.05.023

Lee, 2010, Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations, J Hepatol, 52, 579, 10.1016/j.jhep.2010.01.008

Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, E462, 10.1152/ajpendo.00064.2004

Korenblat, 2008, Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects, Gastroenterology, 134, 1369, 10.1053/j.gastro.2008.01.075

Strauss, 2007, Interobserver and intraobserver variability in the sonographic assessment of fatty liver, AJR Am J Roentgenol, 189, W320, 10.2214/AJR.07.2123

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466

Mofrad, 2003, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values, Hepatology, 37, 1286, 10.1053/jhep.2003.50229

Fracanzani, 2008, Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes, Hepatology, 48, 792, 10.1002/hep.22429

Borai, 2007, The biochemical assessment of insulin resistance, Ann Clin Biochem, 44, 324, 10.1258/000456307780945778

Larter, 2010, A fresh look at NASH pathogenesis. Part 1: The metabolic movers, J Gastroenterol Hepatol, 25, 672, 10.1111/j.1440-1746.2010.06253.x

Gunzerath, 2004, National Institute on Alcohol Abuse and Alcoholism report on moderate drinking, Alcohol Clin Exp Res, 28, 829, 10.1097/01.ALC.0000128382.79375.B6

Niemela, 2007, Biomarkers in alcoholism, Clin Chim Acta, 377, 39, 10.1016/j.cca.2006.08.035

van Werven, 2009, Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content, J Magn Reson Imaging, 30, 444, 10.1002/jmri.21837

Elias, 2009, Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease, Nutrition

Kirk, 2009, Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction, Gastroenterology, 136, 1552, 10.1053/j.gastro.2009.01.048

Yamamoto, 2007, Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease, J Gastroenterol Hepatol, 22, 498, 10.1111/j.1440-1746.2006.04548.x

Petersen, 2005, Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes, Diabetes, 54, 603, 10.2337/diabetes.54.3.603

de Luis, 2008, Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance, Diabetes Res Clin Pract, 79, 74, 10.1016/j.diabres.2007.07.015

Viljanen, 2009, Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance, J Clin Endocrinol Metab, 94, 50, 10.1210/jc.2008-1689

Tendler, 2007, The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study, Dig Dis Sci, 52, 589, 10.1007/s10620-006-9433-5

Benjaminov, 2007, The effect of a low-carbohydrate diet on the nonalcoholic fatty liver in morbidly obese patients before bariatric surgery, Surg Endosc, 21, 1423, 10.1007/s00464-006-9182-8

Gasteyger, 2008, Effect of a dietary-induced weight loss on liver enzymes in obese subjects, Am J Clin Nutr, 87, 1141, 10.1093/ajcn/87.5.1141

Johnson, 2009, Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss, Hepatology, 50, 1105, 10.1002/hep.23129

Sreenivasa Baba, 2006, Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis, J Gastroenterol Hepatol, 21, 191, 10.1111/j.1440-1746.2005.04233.x

Promrat, 2010, Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis, Hepatology, 51, 121, 10.1002/hep.23276

Lazo, 2010, Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes, Diabetes Care, 33, 2156, 10.2337/dc10-0856

Albu, 2010, Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes, Diabetes, 59, 627, 10.2337/db09-1239

St George, 2009, Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors, J Gastroenterol Hepatol, 24, 399, 10.1111/j.1440-1746.2008.05694.x

St George, 2009, Independent effects of physical activity in patients with nonalcoholic fatty liver disease, Hepatology, 50, 68, 10.1002/hep.22940

Kantartzis, 2009, High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease, Gut, 58, 1281, 10.1136/gut.2008.151977

Oza, 2009, A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff, J Gastroenterol, 44, 1203, 10.1007/s00535-009-0115-x

Fraser, 2008, A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial, Diabetologia, 51, 1616, 10.1007/s00125-008-1049-1

Kelley, 2004, Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes, Diabetes Care, 27, 33, 10.2337/diacare.27.1.33

Vilar Gomez, 2009, Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease, Aliment Pharmacol Ther, 30, 999, 10.1111/j.1365-2036.2009.04122.x

Ueno, 1997, Therapeutic effects of restricted diet and exercise in obese patients with fatty liver, J Hepatol, 27, 103, 10.1016/S0168-8278(97)80287-5

Tsai, 2006, The evolution of very-low-calorie diets: an update and meta-analysis, Obesity (Silver Spring), 14, 1283, 10.1038/oby.2006.146

Thomas, 2006, Exercise for type 2 diabetes mellitus, Cochrane Database Syst Rev, 3, CD002968

Koo, 2010, The effects of total energy expenditure from all levels of physical activity vs. physical activity energy expenditure from moderate-to-vigorous activity on visceral fat and insulin sensitivity in obese Type 2 diabetic women, Diabet Med, 27, 1088, 10.1111/j.1464-5491.2010.03045.x